Martin Kankam

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial

Lone B Enebo, Kasper K. Berthelsen, Martin Kankam et al. · The Lancet · 2021 · 286 citations

Phase 1B, Multiple Doses, Medicine +3

Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults

M. Pamela Griffin, Anis A. Khan, Mark T. Esser et al. · Antimicrobial Agents and Chemotherapy · 2016 · 143 citations · Full text

Anti‐KIT monoclonal antibody CDX‐0159 induces profound and durable mast cell suppression in a healthy volunteer study

Diego Alvarado, Marcus Maurer, Richard Gedrich et al. · Allergy · 2022 · 68 citations · Full text

Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study

Robert W. Frenck, C. Buddy Creech, Eric Sheldon et al. · Vaccine · 2016 · 62 citations · Full text

Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial

C. Buddy Creech, Robert W. Frenck, Eric Sheldon et al. · Vaccine · 2016 · 53 citations · Full text